Share Name Share Symbol Market Type Share ISIN Share Description
Weston Medical Group LSE:WMG London Ordinary Share GB0003821625 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p - - - - - - - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 0.00

Weston Medical (WMG) Latest News

Real-Time news about Weston Medical (London Stock Exchange): 0 recent articles
More Weston Medical News
Weston Medical Takeover Rumours

Weston Medical (WMG) Share Charts

1 Year Weston Medical Chart

1 Year Weston Medical Chart

1 Month Weston Medical Chart

1 Month Weston Medical Chart

Intraday Weston Medical Chart

Intraday Weston Medical Chart

Weston Medical (WMG) Discussions and Chat

Weston Medical Forums and Chat

Date Time Title Posts
31/1/200815:11WMG ...........10p...........next week8,993
28/12/200514:56administration viz chapter 111
21/5/200510:48Bouncing off their bottom?155
19/4/200423:52Weston medical scales up production21
05/11/200322:43Do Not Throw Away Those Certificates2

Add a New Thread

Weston Medical (WMG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Weston Medical trades in real-time

Weston Medical (WMG) Top Chat Posts

DateSubject
27/9/2016
09:20
Weston Medical Daily Update: Weston Medical Group is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker WMG. The last closing price for Weston Medical was -.
Weston Medical Group has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 0 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Weston Medical Group is £0.
11/4/2004
15:03
tiraider: Hi MW and Fris, Pleased to see that there are no losses of humour here and hope you are both well!! Haven't held ETL for a while, but still watching and waiting.... In the meantime, the fares have been reduced to more competitive levels, so we have taken advantage of that (instead of the cheap share price). I've introduced an online quote and booking system now so I no longer get enquiries for dates already booked, so now I have some extra time to post... So should I short William Hill's? This one's worth backing... Good luck to all rgds tr
15/1/2004
08:25
jumbo66: From UK-Analyst.com: January 14th 2004 Not even another dose of dismal Christmas trading statements from the retailers could spoil the party of the equity markets yesterday as bid action resurfaced on both sides of the Atlantic. Throw in some helpful economic data, a decent day for the dollar and no-one (apart from the retailers and the bears) was complaining. In the UK the bid action centred around Egg. In the US AT&T Wireless was (according to the Wall Street Journal) in play and after the bell it was announced that JP Morgan was splashing out $58 billion to buy Chicago based Bank One - one of the largest bank mergers in history. Sentiment Stateside was also boosted by news that the Trade Deficit last month had shrunk (due to the weak dollar) and that provided some support to the Greenback which closed up on the day. At the close the Dow was 111.19 points up at 10,538.37 and the Nasdaq was 14.69 points ahead at 2,111.13 - in both cases about half of those gains being racked up during the London day. On domestic shores the FTSE 100 ended 21.3 points ahead at 4,461.4, the FTSE All-Share was 11.57 points up at 2,213.88 and the FTSE TechMARK was 8.75 points ahead at 1,068.16. Broker Upgrades/Downgrades: With airlines suddenly hot to trot, EasyJet raced ahead thanks to broker CSFB. It increased its price target on the stock to 375p as it upped its forecasts and reiterated its "outperform" stance and that saw the shares climb by 28.25p to 370.5p. Sticking with travel: Carnival added 72p to 20 as Dresdner Kleinwort Wasserstein suggested that the weak dollar would boost business and that this made the stock look cheap. Heading the other way was SABMiller (off 5p at 551.5p). Deustche Bank told its clients to "sell" the stock after the recent trading update inspired rally while UBS pared its target price to 570p from 580p but remains more positive. In the tech sector Autonomy slipped back by 14p to 285p as UBS downgraded its stance to "neutral" from "buy" - the stock raced ahead earlier in the week thanks to a big Citigroup upgrade. Legal & General advanced by 4.75p to 104.5p thanks to Merrill Lynch which said that it was its preferred stock in the sector and set a target price of 125p for the shares. Blue-Chip Movers On the high street Dixons (up 7.75p at 153.5p) provided the good news. It announced that its first half pre-tax profits were up by 9% at .7 million, earnings were 3% ahead at 3.7p and hiked its payout by 10% to 1.66p. More critically it enjoyed a good Christmas with overall sales up by 12% and like for likes 5% ahead. Brokers reacted positively. At Evolution Beeson Gregory, retail guru Nick Bubb upped his (top of the range) full year forecast up by illion to million (12.2p of earnings) ad increased his 2005 forecast by illion to million. Bubb notes that on a forward yield of 4.7% the stock is still attractive and increased his target price to 180p from 165p while sticking with his "buy" stance. Marks & Spencer was not so good. Its Christmas like for likes (minus 2.3% overall, -4.1% in non food) were bad enough to prompt the head of clothing David Norgrove to walk the plank but they were not bad enough to prompt broker downgrades. The company had some comforting words to say on margins and analysts held full year forecasts steady at around million. Relieved that there were no downgrades traders marked the shares up by 2p to 276.25p. Among those arguing that the bad news was already more than discounted was Tony Shiret at CSFB who rates the stock "outperform." Wolseley also served up a positive trading statement covering the five months to December 31st with sales and profits ahead by 25.2% and 26.5% respectively. It noted that in the UK trading had improved since the November AGM. Citigroup Smith Barney was among those pushing the stock as a "buy" and its shares jumped 43.5p to 787p. Mid Caps: Star of the day was Internet Bank Egg. Its shares rocketed 44p to 169p as the Prudential (up 20.75p at 490.5p) confirmed that it was in talks to sell its 79% stake. The rumoured purchaser is America's MBNA. While it is no surprise that the Pru wants the moolah, Egg's current share price values each of its credit card customers at c which looks a trifle generous. The renewal of merger activity among the alternative telcos saw Colt Telecom advance by 5.75p to 115.5p (assisted by WestLB rating the stock "outperform" albeit with a 110p target) and Thus pipe up by 2.25p to 38p while ahead of quarterly earnings numbers from Intel, traders bet that it would be good news for the chip industry and ARM Holdings rose by 7.75p to 138.25p. And then there were the retailers. Worst first. Matalan (down 13.25p at 156.75p) served up another horror. Just a few months ago brokers had hoped that in the year to end February pre-tax profits would be c million. Then a pre-Christmas profits warning hauled that number back to million and after a useless Christmas Matalan now reckons it will make just 70 million as Festive like for likes fell by 5% with margins in the 19 weeks to January 5th down by 1.9% and still Matalan has a load of stock to clear. Arbuthnot's reaction was typical. It says the chances of a bid are not that great and sees profits hitting 7 million this year (earnings of 10.7p) and 4 million in 2005 (earnings of 14.9p) but all credibility has gone and it downgraded its stance to "sell" from "hold." On the other hand Lastminute.com indicated that its first quarter (to December 31st) had been at least in line with forecasts (if not stronger) and also announced the million acquisition of First Option Hotel Reservations in a deal which it said (as it always says) would be "earnings enhancing." The company still has not produced its promised apology from Terry Smith and Collins Stewart for the excellent note which pointed out how aggressive Lastminute's accounting policies are. Lastminute's shares added 13p to 223p. Meanwhile JJB Sports soared 30.5p to 268p after accompanying a patchy festive update (Christmas like for likes down 3.5% but margins up and a strong start to January) with news that it would be hiking its final dividend by 40% and that ABN Amro will be buying back up to million of its shares (6.01%-7.01% of the share capital) in the market as a result of a tender offer because JJB's debts are minimal and because it is so cash generative. Rival JD Sports promised no share buyback and its Christmas numbers were worse than patchy and that after a poor start to the New Year it warned that its full year numbers would not meet forecasts and its shares slipped by 5p to 167.5p. Small Caps, AIM and Ofex: Star of the day was PGM explorer Eurasia (up 1.75p at 8.125p) which announced that it had won permission to start drilling its acreage at Kliprivier in the Bushveld and said that it would start drilling next month. The area is pretty close to the huge Everest South find of Aquarius Platinum (up 6.75p at 387p on the back of continuing strength in the platinum price). Troubled vehicle management data services group Minorplanet Systems rose 3pt to 42p after it agreed with GE, its largest shareholder, on the terms of a m loan facility as it looks to fund its cost reduction programme and the ongoing working capital needs of the business. Finance director David Best also walked the plank. Deltex Medical added 3.5p to 26.5p after it announced that it expects to report calendar 2003 sales up by 70% (in line with market forecast) at million and that it still has net cash of . million. Deltex is now valued at 4 million. Meanwhile Mean Fiddler jumped 2p to 40p as it announced that it had won the rights to stage Britney's European tour this summer. Cash shell Netcentric is - as we have warned before - no bargain and the New Opportunities Investment Trust is clearly in agreement. News that it had lobbed out two million shares saw the stock lose 0.125p to close at 0.52p. Meanwhile ail listed Maisha was suspended at 2.75p. It says that it has net cash and is still viable but that the financial position of Pearl ( a company it was buying) was not certain and that until the auditors to Pearl answered a few easy questions its shares would remain suspended. Dog of the day was Cassidy Brothers (off 14p at 40.5p) which announced that its interim profits had fallen by almost two thirds to ,000 and was unable to provide comprehensive reassurance that the rest of the year would be that much better.
19/10/2003
17:37
tiraider: Break-up on cards for Kingston Simon Fluendy, Mail on Sunday 19 October 2003 PHONE and internet group Kingston Communications is set to be broken up in a deal likely to see rival Thus take the lion's share of the business, including Hull's famous white telephone boxes. The deal, in which Thus would offer shares for the business, would pave the way for Hull City Council to reduce the 41% stake it retained after floating the local phone network in 1999. Energis and Colt Communications may also take small parts of Kingston, which last month abruptly sacked chief executive Steve Maine. It was initially claimed that Maine departed after failing to achieve his promise to turn round Kingston's troubled business services division. But City sources now say that Maine clashed with the board over strategy. Malcolm Fallen, formerly finance director but now acting chief, and other directors thought that a break-up of Kingston was the most sensible strategy. It is believed that Maine disagreed. 'Fallen has wanted to dice the company up for a while,' a source said. 'It looks as if he will now get his chance.' Hull City Council, which has two members on the Kingston board, has been briefed. The local MP, Deputy Prime Minister John Prescott, MP, is also said to have been kept informed. 'Given that so many of his constituents own shares and the strong local interest, it would be very unlikely that John had not been briefed,' said one local. Fallen is expected to be confirmed as chief executive within weeks and this is expected to be the starting gun for a new round of talks. 'There have been a number of approaches to Kingston over the past 12 months but it should be stressed that there is nothing active at this moment,' one source said. Fallen is believed to have launched a cost-saving drive. 'He will find one or two City-pleasing moves to try to bolster the share price before accelerating the sale process,' the source added. Thus refused to comment. 'There are always a lot of rumours in the telecoms industry and we don't ever comment,' a spokeswoman said. But sources close to Thus said Kingston would be 'a good fit', while its consumer business generates significant earnings that Thus could use to fund expansion. 'That area of the country is a bit of a blackhole for Thus's network,' a source said. 'So Kingston would be a good fit.' Representatives of Energis are also understood to have held talks with Kingston, currently worth £230 million, but chairman Archie Norman only wants small parts of the company. ALSO; http://www.advfn.com/p.php?pid=nmona&cb=1066581706&article=5765076&symbol=LSE%3ATHUS
02/10/2003
08:35
tiraider: WSLS; Same article I think, it was emailed to me by Business Weekly; By Business Weekly, 30 September 2003 The American company which bought the needle-free drug delivery technology of Cambridge based Weston Medical in a fire sale is already seeing signs of promise in the product, writes John Fenton. The American company which bought the needle-free drug delivery technology of Cambridge based Weston Medical in a fire sale is already seeing signs of promise in the product, writes John Fenton. The trial faults which took Weston into administration after its share price went into free fall seem to have been well and truly ironed out, according to data supplied by new owner Aradigm Corporation. As a result of the trials, featuring different configurations of the technology, Aradigm says that "at least one of these configurations enables a commercially viable product to be used across a wide variety of drugs." Stephen Farr, who is Aradigm's chief scientific officer said: "This now allows us to map out the next steps in the Intraject development program taking us through the remainder of 2003. "I am pleased with the progress made in integrating this acquisition and in the abilities of the Intraject team, led by Toby King, formerly of Weston Medical." The trial was carried out earlier this year by Weston Medical as part of its work to resolve a tolerance stack-up issue, identified in Q3 2002, which resulted in unacceptably high rates of incomplete injections in some subjects. Following the recent completion of the technology transfer phase of the acquisition, Aradigm rev-iewed this data and reached these conclusions regarding the configuration. "These data provide us with a much clearer picture of the parameters needed by the Intraject system to efficiently deliver a wide range of drugs," said King, Aradigm's senior technical director for Intraject. "We will use this information to refine and complete an in vivo/in vitro correlation, and to select and test the final commercial configuration of Intraject. "This will then allow us to go forward to the final cinical performance verification trial that we anticipate will occur in 2004. "Successful completion of this trial will be the trigger for our licensees to commence their bioequivalence studies to demonstrate that Intraject is comparable to the subcutaneous injection delivery of their compounds." Dumped MDY on a stoploss when it fell thru 21s, so avoided the big one! Hope you weren't caught holding. I'm watching it at the moment; I expect some consolidation at this level, no immediate reason to get back in yet awhile. Rgds to all tr
23/4/2003
13:50
tiraider: From iii Evil Knievil: Shorting the penny dreadfuls Evil Knievil Guest columnist Evil Knievil is Britain's best-known bear raider. Last year he says he made £3 million from shorting: betting a company's shares will fall in price. Evil reveals the risky world of the shortseller where bear markets are good news, losses are potentially unlimited and he bets against the interests of ordinary shareholders. Catch Evil at Bear Essentials, his one-day shorting masterclass on May 31st Shorting penny stocks is not always easy. In fact it can be easier trying to catch President Chirac behaving in a half-decent manner. But it can be rewarding. Not quite as rewarding as selling nuclear reactors to Saddam Hussein. But still rewarding. By penny stocks I mean companies with a share price of less than 100p and a market capitalisation of less than £100 million. Others will have alternative definitions but for the sake of argument let's assume that I am correct. I usually am. Fallen stars and companies tipped for greatness are the shorter's dream Penny stocks fall into four categories. Some are real growth situations at the start of their career. In this case this is of no interest to me although when they go ex-growth and their management lose touch with reality I will be back. Others are dull perennial also-rans. Boring engineering companies on a PE of 6 are of no interest to me. Or to anyone else for that matter. That is why they will always be boring engineering companies on a PE of 6. I shall leave such concerns to men with greasy hair and cheap suits from the West Midlands. The third category is the fallen stars. Companies such as Marconi and British Energy were once among the great and the good of the FTSE 100. Now they are penny shares. And the final category is those tipped for greatness, which they will never achieve. It is the fallen stars and those tipped for greatness that are the shorter's dream. Surely Marconi can fall no further? Surely, I hear you scream, Marconi shares have already fallen from £10 to 1.7p they can fall no further. You would of course be wrong. For any share whether its share price is 1p or £100,000 the maximum percentage downside is 100%. And the fact that once mighty industrial monoliths have already fallen by 99% should indicate to you that they are considered by many to be bust. As such it will not take much for them to go the final yard and to actually go bust. For if you short £10,000 worth of a stock at 100p and it goes bust you make exactly the same return as if you short £10,000 worth of stock at 1p and it goes bust. So why not increase your chances of hitting pay dirt by targeting those companies that are already floundering. As it happens Marconi is not going bust. But it has agreed to a debt for equity swap, which will leave ordinary shares so heavily diluted that they are worth only around 0.1p. So I may not be hitting the bull's-eye with Marconi but I am sure to be pretty close. The same applies to British Energy. Regus In the same sort of category is serviced offices group Regus. I have been shorting this stock all the way down from a peak of around 400p to today's 22p. It has already put its US arm into Chapter 11 and seems to me to be an appallingly badly run company with a weak balance sheet facing a massive cyclical downturn. That was the situation at 400p and it is the same at 22p. Ashtead I put Plant Hire group Ashtead in the same boat: lets call it the Marie Celeste. Again I have been shorting these shares for about five years from 240p all the way down to today's 6.75p. Indeed I have been adding to my position of late. This company has a horrid balance sheet and has finally admitted to having accounting issues. It survives, for the time being, only with the blessing of its banks. In such circumstances, its equity cannot have any value. The only problem is not whether to kick but how to land your blow You may say that kicking a man when he is down is rather bad form. That is as may be. But if you want to make money on the short tack, there is never a better time to kick a man than when he is down. In cases such as Marconi the problem is not whether to kick but how to land your blow. That is because spread-betters such as Cantors or IG Index may not actually take a bet on such stocks. Hence, with Marconi at least, I find myself having to employ a traditional broker and selling short on a T+20 basis with the knowledge that because I must settle in twenty days, I shall have to roll my position over at least once before the gravy arrives. Kicking a fallen star is easy money and all easy money is enjoyable. But it can be even more entertaining and just as profitable, taking pot shots at those over-hyped penny stocks that insist they are on the verge of greatness. Minmet My battles with overhyped gold explorer Minmet were made all the more enjoyable by the way the company wriggled and its shareholders berated me on the bulletin boards. The joy of taking on such enterprises is that every time you wish to sell stock there is always an army of 'true-believers' who will happily buy it from you. And when a company calls in the twin pillars of the blood-sucking establishment - lawyers and regulators - you know you are onto a winner. You only dance with such creatures when you are desperate. The difficulty of shorting such enterprises is they are invariably recommended by every tipster in town. Hence your positions can run against you in heart-stopping spikes. As such you need deep pockets and nerves of steel as you take every tipsheet ramp as an opportunity to increase your short. Griffin mining You might argue that such over-hyped penny stock dreadfuls are creatures that only emerge during a bull market but you would be surprised. Have a look at the chart of Griffin Mining a little gold explorer operating in China. What are its tangible assets? Not a lot. Yet every day brings some new crank telling me that I should have a look because Griffin is the best thing to come out of China for years. As far as I can see the only other thing coming out of China is the Sars virus so the competition is not that hot but I am still short of Griffin. Sportingbet For different reasons I remain short of Sportingbet an AIM listed Internet gambling company that (supporters claim) will be making a pre-tax profit of £30.5 million by the year to March 2005. At 18p it is capitalised at £29 million. So is this truly a wonderful penny share growth stock? Not in my book. The company is dogged by legislative and balance sheet uncertainties and having been short all the way down from 100p my price target remains 2p. Or lower. The old saying is that penny stocks are not for widows and orphans. Au contraire. For me there are few safer investments than a good short or two among the penny dreadfuls.
23/4/2003
07:31
tiraider: Good morning all WMGers, Very nice bright start for us this morning. MDY have just made their AGM announcement which looks good for their share price today and into the longer term. A lot of upside still to come with ELH after the bid approach yesterday..... This is from Citywire: Eurodis is latest prey for growing army of bidders Published: 18:01 Tue 22 April 2003 By Algernon Craig Hall, Secret Buying Correspondent Email to a friend | Printable Version Shares in Europe's third largest electronics components distribution company Eurodis Electron jumped 32% today on news of a takeover approach and the company's largest shareholder reckons there could be much more upside to come. It is likely that today's approach will have come from an international trade buyer such as Arrow Electronics or Avnet, both of which have announced they are following acquisitive policies. No value has been put on the bid, which is said to be at a very early stage. AAA-rated fund manager Peter Webb, whose Unicorn Asset Management investment company owns 29.5% of Eurodis, is not surprised that the distributor has received an approach and reckons smaller companies are set for a wave of consolidation. Webb told Citywire: 'I expect a material pick up in corporate interest in oversold industrial and corporate services businesses.' He added: 'Valuations have never been so cheap [for bids] to succeed premiums will have to be stonkingly high.' A recent acquisition of Pioneer-Standards' US electronics components arm by Arrow suggests a bid for Eurodis (ELH) could be at a substantial premium to the £19 million market value that Eurodis has achieved following today's rises. Pioneer's electronics components business, which is in effect a US equivalent of Eurodis, was bought in January for US$285 million cash. This valued Pioneer's business at 40% of the annual turnover Arrow said it expected from it. If Eurodis were valued at 40% of its expected turnover for the current year it would be worth over £120 million. Even if one removes about £40 million net debt from that price this would give a eye boggling premium to the price implied by the market. Any bid is likely to be pitched lower than 40% sales given where the shares have started from, but there is still potential for considerable upside. A strong and much vaunted general consolidation theme has begun to emerge recently. Takeovers of large companies, especially in consumer related lines of business, have begun to filter down to the smaller companies arena where some of the most tempting takeover prospects are to be found. Today in the smaller companies universe Freeport announced a possible management buyout in addition to the news from Eurodis. And just before the market closed ahead of the Easter weekend property services group Hercules announced that it was the subject of an approach. Webb believes a key factor that will drive consolidation is the big disparity between the valuations put on smaller companies compared with their larger peers. He thinks the valuation discrepancy is especially pronounced. In his opinion bidders are more likely to look at a target's sales and gross profits rather than its bottom line, which is likely to show most weakness in prevailing weak trading conditions. The rationale behind his belief that larger companies will focus on gross profits rather than pre-tax or post-tax profits is that big buyers should be able to eliminate central costs from small bolt on acquisitions. This should mean such acquisitions will prove extremely earnings enhancing for large buyers. Webb said: 'The need for consolidation has never been so great from a business point of view.' However, a key stumbling block for some of these potential bids in the smaller companies arena could turn out to be the reluctance of large shareholders and management to accept low and opportunistic offers at the bottom of the trading cycle. This could act as a deterrent to the spread of bid fever but could also force higher premiums. Webb and his team at Unicorn have targeted a number of cyclical companies that could make good bid fodder if the current momentum behind consolidation continues to grow. Possible candidates range from other battered electronics companies like Eurodis, such as Pressac (PRSC) and Volex (VLX) to trampled recruitment firms like MSB International (MSB) and Harvey Nash (HVN). Consolidation certainly looks like a theme investors should now be paying attention to and Citywire will continue to track those companies with corporate action potential closely. ©2003 Citywire Good luck to all rgds tr
28/2/2003
17:44
zengas: Why did the big three stay in? (Nomura, 3i, Phildrew) Why did the Finance director depart back in November? Push, shove, I don't like the route we're going down??? Why have WMG the full support of their Licencees etc? Pardon and excuse me if i am wrong but was it not a Nomura? analyst not so long ago who set a price target of £3++++ on these shares. Why?, when they have so many partners/licencees prepared to use their technology is this seemingly being allowed to go to the wall? Why did re-finance talks suddendly break up and now the administrators in quick succession ? Why no news of the design faults? (As shareholders do we not have a right to know) Why did the company not put forward the possibility of a rights issue direct to us the ordinary shareholders? Why do i feel that this is a scenario that best suits others. ie pick up the pieces for a song and continue the merry story. Why as a shareholder holding thousands of these certificates do i feel shafted, and left with more qusetions than answers. OMH recently dropped 95% in share value, never had a product to market and battled on with FDA apoproval on devices they were developing. They neither had partners or licencees, yet they sure as hell raised excellent funding, privately and publicly in these dire markets which i had the opportunity to subscribe to. (£5M circa I think they raised barely a few months ago) They also had sweet F.A in terms of institutional investors yet WMG had plenty and we were told on the threshold of a multi billion pound market, hence the analysist share price forecast. I think the whole show stinks. I won't be grovelling to Mr Samler saying hard luck, you did your best. As a shareholder I am entitled to know what the hell has been going on here. I want Mr Samler and Co to provide answers!!!!!!!!!!!!!!!!
18/2/2003
21:59
slapmewithakipper: Did the leaked 1p open offer price ! Affect the wmg share price ?
04/2/2003
09:53
pretax: Hi TI, BBand say 6.3, but somewhere in that region I guess. But my point is that, bar a few moments of hyped excitement, the WMG share price has moved nowhere but down (on the grand scheme of things) as confidence has waned. Look at the trading ranges on the day chart during the beginning of November [S6.5 R7.0]: then mid Nov to mid Dec [S6.0 R6.5]: then now [S5.5 R6.0]. Here WMG appears to be falling through successive levels of immediate support over time. Without news, it is only logical to believe that this trend will continue. PT
08/10/2002
17:06
matt1231: Share price volatile whilst the question of funding remains. Remember the company as yet DON'T have a product that works and therefore cannot be sold. Funding will be therefore required to continue development/modifications and for the company to survive. Whilst this uncertainty remains the question of what company is worth is up for debate.Institutions dumped as low as 2p subsequent to which investors/traders saw wild volatile swing trading share prices.My opinion on shares like this was to take profits when you have them and not get too greedy. WMG imo remains a highly speculative punt until funding issue is resolved.Among many options is possibly a rights issue,in which case a what price and what effect upon share price-between 10p and 2p or less? In the interim period share price like many others is at the mercy of the markets,sentiment,buyers & sellers and is currently trending down.Highly speculative.IMHO,DYOR.
Weston Medical share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20160927 17:17:28